← SynDRA
HYDRALAZINE
SynDRA canonical compound SYN0000484 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | MPO |
| Mechanism of action | myeloperoxidase inhibitor | vasodilator |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
- MPO
- ALOX15
- AOC3
- AOX1
- BCHE
- CACNA1C
- DNMT1
- DNMT3A
- DNMT3B
- GOT1
- LPO
- RYR2
Mechanisms of action (all sources)
- myeloperoxidase inhibitor
- vasodilator
- AOC3 MODULATOR
- RYR2 BLOCKER
Drug classes
- Arteriolar Vasodilator
- Antihypertensive Agents
- Cardiovascular Agents
- Vasodilator Agents
ATC classes
- C02D · ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
- ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
Cross-references
Synonyms
- hydralazine hydrochloride
- hydralazine HCl
- Hidralazina
- NSC-126699
- Hydralazine polistirex
- Apresolin
- Apresoline
- Apressin
- Apressoline
- Aprezolin
- HLZ
- Hidral
- Hidralazin
- Hipoftalin
- Hydralazin
- Hydralazinum
- Hydrallazin
- Hydrallazine
- Hydrazinophthalazine
- Hypophthalin
- Idralazina
- Hidralazina [Spanish]
- Idralazina [DCIT]
- Idralazina [Italian]
- BA 5968
- C-5968
- Ciba 5968
- Praparat 5968
- Apresoline (TN)
- Apressin (pharmaceutical)
- C-5068
- Hidral (TN)
- Hidralazina [INN-Spanish]
- Hydralazine (INN)
- Hydralazine [INN:BAN]
- Hydralazinum [INN-Latin]
- Hydrazone 1(2H)-phthalazinone
- Phthalazin-1-ylhydrazine
Reported adverse events
- Headache
- Hypersensitivity
- Dizziness
- Abdominal discomfort
- Amblyopia
- Asthenia
- Chromaturia
- Dysgeusia
- Erythema
- Facial pain
- Hepatitis
- Hypotension
Look up HYDRALAZINE in the interactive SynDRA portal →